Medical device company
Appears in 1 story
Listed on ASX, commercializing Symphony in the US
Aroa Biosurgery published results from a randomized controlled trial showing its Symphony wound dressing heals diabetic foot ulcers faster than standard care. The study, in the International Wound Journal, found 55% of ulcers closed within 12 weeks with Symphony, versus 35% with standard care alone.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
